Mercaptopurine
Back to searchMolecule Structure
Scientific Name
Mercaptopurine
Description of the Drug
Mercaptopurine is an antineoplastic agent used to treat acute lymphocytic leukemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01033
http://www.drugbank.ca/drugs/DB01033
Brand Name(s)
Purinethol
Company Owner(s)
Stason Pharmaceuticals Inc, Nova Laboratories Ltd, Dr Reddys Laboratories Sa, Mylan Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Amidophosphoribosyltransferase | SINGLE PROTEIN | INHIBITOR | CHEMBL2362992 |
Clinical Trial(s)
Unichem Links
Atlas | mercaptopurine | |||||||
SureChEMBL | SCHEMBL3893 | |||||||
PharmGKB | PA450379 | |||||||
Human Metabolome Database | HMDB0015167 | |||||||
DrugBank | DB01033 | |||||||
PubChem: Thomson Pharma | 14772317 | 15321640 | 15970891 | |||||
PubChem | 667490 | |||||||
Mcule | MCULE-4811219863 | |||||||
NMRShiftDB | 60062490 | |||||||
LINCS | LSM-5963 | |||||||
Nikkaji | J2.298E | |||||||
PDBe | PM6 | |||||||
BindingDB | 50423778 | |||||||
EPA CompTox Dashboard | DTXSID0020810 | |||||||
DrugCentral | 1708 | |||||||
Brenda | 1345 | 105222 | 105221 | 157386 | 46631 | 30171 | 112781 | 12401 |
Rhea | 50667 | |||||||
ChemicalBook | CB1425059 | CB42610065 | ||||||
Guide to Pharmacology | 7226 | |||||||
rxnorm | PURIXAN | MERCAPTOPURINE | MERCAPTOPURINE ANHYDROUS | |||||
KEGG Ligand | C01756 | C02380 | ||||||
ChEBI | 94796 | 50667 | 2208 | |||||
ZINC | ZINC000004658290 |